In Focus

Patients fighting life-threatening illnesses who have run out of conventional options will get a chance to try some of the most cutting-edge treatments available, through a national effort that just received nearly $4.8 million in funding from the federal government.

Based at the University of Michigan, in partnership with Duke University, the University of Texas Southwestern Medical Center and the University of Rochester, the effort will build a national framework to help more patients gain access to experimental drugs, devices and biologics. It is funded by the National Center for Advancing Translational Sciences, part of the National Institutes of Health.

CBSSM News & Events

Tom Valley awarded Career Development Award
Tom Valley was recently awarded an NIH/NHLBI K23 Career Development Award. Dr. Valley’s award seeks to prevent avoidable deaths from pneumonia by improving the use of the ICU.
Read more.
Jeff Kullgren interviewed by The Inquirer on medical procedure pricing 08/13/2018
Jeff Kullgren was recently interviewed by The Inquirer (Philadelphia) on skewed medical procedure pricing and its impact on patients.
Read more.
CBSSM Working Group Meeting-Andy Shuman, MD & Susan Goold MD 08/21/2018
Andrew Shuman MD, Assistant Professor in the Department of Otolaryngology - Head and Neck Surgery and Susan Goold, MD, Professor of Internal Medicine and Health Management and Policy; will be seeki
Read more.